Endometriosis and Frequency of Endometriosis-associated Ovarian Carcinomas (EAOC)

Endometriosis and Frequency of Endometriosis-associated Ovarian Carcinomas (EAOC) - Epidemiological and Molecular Pathological Aspects

Status

Withdrawn

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01732432

Acronym

EAOC

Enrollment

Registered

2012-11-22

Start date

2012-10-31

Completion date

2013-12-31

Last updated

2015-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Clear Cell Carcinoma, Endometrioid Carcinoma, Endometriosis

Brief summary

The purpose of this study is to determine whether a relationship exists between a previously established diagnosis of endometriosis and the consecutive risk of developing a clear cell or endometrioid ovarian carcinoma. All histopathological records since 1980 with these diagnoses (endometriosis, clear cell and endometrioid ovarian carcinoma) will be reviewed. Cancer registry data will be assessed to investigate differences in survival of women with endometriosis-associated ovarian carcinomas and those ovarian carcinoma patients without previous diagnosis of endometriosis.

Interventions

None listed

Study design

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

30 Years to 85 Years

Healthy volunteers

Inclusion criteria

* endometrioid ovarian carcinoma * clear cell ovarian carcinoma * endometriosis, atypical endometriosis * borderline tumors with endometriosis

Exclusion criteria

* undifferentiated carcinomas * germ cell tumors * sex cord-stromal tumors

Design outcomes

Primary

Measure	Time frame
incidence and clinical outcome of endometriosis-associated ovarian carcinomas	30 years

Outcome results